Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Intravesical doxorubicin for prophylaxis in the management of recurrent superficial bladder carcinoma.

Intravesical doxorubicin for prophylaxis in the management of recurrent superficial bladder carcinoma. J Urol. 1984 Jan; 131(1):43-6.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.